All articles tagged with #islet cells
A new stem cell treatment developed by Vertex Pharmaceuticals shows promise in curing severe type 1 diabetes, with a clinical trial demonstrating significant improvements and reduced insulin dependence in most participants, though further studies are needed to confirm long-term benefits.
Researchers from Cornell and the University of Alberta have developed a new technique to treat Type 1 diabetes by implanting a device under the skin that can secrete insulin without the need for immunosuppression. The device, named SHEATH (Subcutaneous Host-Enabled Alginate THread), is inserted into a pocket created by nylon catheters, allowing blood vessels to form around it. The device provides a long-term and less invasive alternative to insulin injections or traditional transplants, and future versions may last for two to five years before needing replacement. Additional research is needed to support long-term functionality in large-animal models and eventually patients.